Perforation de la cloison nasale et bevacizumab

Autor:	Christophe Tournigand, Leila Bengrine-Lefevre, Pauline Afchain, H. Gervais, Benoist Chibaudel, De Gramont A, C. Louvet
Rok vydání:	2011
Předmět:	medicine.medical_specialty Nasal septum perforation Bevacizumab business.industry Gastroenterology respiratory system medicine.disease Metastatic breast cancer Surgery chemistry.chemical_compound Paclitaxel chemistry otorhinolaryngologic diseases Internal Medicine medicine business medicine.drug
Zdroj:	La Revue de Médecine Interne. 32:e43-e45
ISSN:	0248-8663
DOI:	10.1016/j.revmed.2010.04.015
Popis:	A 52-year-old woman, with a metastatic breast cancer, presented with a nasal septum perforation while receiving a treatment combining paclitaxel and bevacizumab. This is the fifth reported case of nasal septum perforation probably related to an anti-angiogenic therapy. A literature review and a discussion concerning the different causes of nasal septum perforation were performed.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::3d12ea9bd9a24dbe530e813d913c750d https://doi.org/10.1016/j.revmed.2010.04.015 Zobrazit plný text záznamu Full Text from ScienceDirect